(Reuters) - Warren Buffett's Berkshire Hathaway Inc on Wednesday said it has taken a new stake in Teva Pharmaceutical Industries Ltd , significantly boosted its holdings of Apple Inc and has nearly shed a less successful investment in IBM Corp .
In a regulatory filing detailing its U.S.-listed stock holdings as of Dec. 31, Berkshire reported owning about 18.9 million of the American depositary receipts in Teva, one of the world's largest generic drug makers, worth about $358 million.
Teva's share price rose more than 10 percent after Berkshire reported its ownership stake.
Berkshire also reported a 23 percent increase since the end of September in its Apple stake, to about 165.3 million shares, and a 94.5 percent decline in its stake in International Business Machines Corp, to 2.05 million shares.
(Reporting by Jonathan Stempel in New York; Editing by Leslie Adler)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
